Venous Thromboembolism Therapeutics Market - Global Outlook and Forecast 2021-2027

Code: RW00014562128
Market Monitor Global
Oct-2021
Life Sciences
102 Pages

This report contains market size and forecasts of Venous Thromboembolism Therapeutics in Global, including the following market information:
Global Venous Thromboembolism Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Venous Thromboembolism Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Venous Thromboembolism Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Venous Thromboembolism Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Venous Thromboembolism Therapeutics Market Segment Percentages, By Type, 2020 (%)
Factor Xa Inhibitors
Direct Thrombin Inhibitors
Heparin
Vitamin K Antagonists
Other

China Venous Thromboembolism Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Venous Thromboembolism Therapeutics Market Segment Percentages, By Application, 2020 (%)
Hospital Pharmacies
Retail Pharmacies
Other

Global Venous Thromboembolism Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Venous Thromboembolism Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Venous Thromboembolism Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Venous Thromboembolism Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Johnson & Johnson
Sanofi
Boehringer Ingelheim
Daiichi Sankyo
Bristol-Myers Squibb (BMS)
Bayer HealthCare
Pfizer
Leo Pharma
Portola Pharmaceuticals
ThromboGenics
Ionis Pharmaceuticals
GlycoMimetics
BioInvent International

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Venous Thromboembolism Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Venous Thromboembolism Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Venous Thromboembolism Therapeutics Overall Market Size
2.1 Global Venous Thromboembolism Therapeutics Market Size: 2021 VS 2027
2.2 Global Venous Thromboembolism Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Venous Thromboembolism Therapeutics Players in Global Market
3.2 Top Global Venous Thromboembolism Therapeutics Companies Ranked by Revenue
3.3 Global Venous Thromboembolism Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Venous Thromboembolism Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Venous Thromboembolism Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Venous Thromboembolism Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Venous Thromboembolism Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Venous Thromboembolism Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Venous Thromboembolism Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Factor Xa Inhibitors
4.1.3 Direct Thrombin Inhibitors
4.1.4 Heparin
4.1.5 Vitamin K Antagonists
4.1.6 Other
4.2 By Type - Global Venous Thromboembolism Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Venous Thromboembolism Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Venous Thromboembolism Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Venous Thromboembolism Therapeutics Market Size, 2021 & 2027
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Other
5.2 By Application - Global Venous Thromboembolism Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Venous Thromboembolism Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Venous Thromboembolism Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Venous Thromboembolism Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Venous Thromboembolism Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Venous Thromboembolism Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Venous Thromboembolism Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Venous Thromboembolism Therapeutics Revenue, 2016-2027
6.3.2 US Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.3.3 Canada Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.3.4 Mexico Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Venous Thromboembolism Therapeutics Revenue, 2016-2027
6.4.2 Germany Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.4.3 France Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.4.4 U.K. Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.4.5 Italy Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.4.6 Russia Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.4.8 Benelux Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Venous Thromboembolism Therapeutics Revenue, 2016-2027
6.5.2 China Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.5.3 Japan Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.5.4 South Korea Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.5.6 India Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Venous Thromboembolism Therapeutics Revenue, 2016-2027
6.6.2 Brazil Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.6.3 Argentina Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Venous Thromboembolism Therapeutics Revenue, 2016-2027
6.7.2 Turkey Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.7.3 Israel Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Venous Thromboembolism Therapeutics Market Size, 2016-2027
6.7.5 UAE Venous Thromboembolism Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Venous Thromboembolism Therapeutics Major Product Offerings
7.1.4 Johnson & Johnson Venous Thromboembolism Therapeutics Revenue in Global (2016-2021)
7.1.5 Johnson & Johnson Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Venous Thromboembolism Therapeutics Major Product Offerings
7.2.4 Sanofi Venous Thromboembolism Therapeutics Revenue in Global (2016-2021)
7.2.5 Sanofi Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Venous Thromboembolism Therapeutics Major Product Offerings
7.3.4 Boehringer Ingelheim Venous Thromboembolism Therapeutics Revenue in Global (2016-2021)
7.3.5 Boehringer Ingelheim Key News
7.4 Daiichi Sankyo
7.4.1 Daiichi Sankyo Corporate Summary
7.4.2 Daiichi Sankyo Business Overview
7.4.3 Daiichi Sankyo Venous Thromboembolism Therapeutics Major Product Offerings
7.4.4 Daiichi Sankyo Venous Thromboembolism Therapeutics Revenue in Global (2016-2021)
7.4.5 Daiichi Sankyo Key News
7.5 Bristol-Myers Squibb (BMS)
7.5.1 Bristol-Myers Squibb (BMS) Corporate Summary
7.5.2 Bristol-Myers Squibb (BMS) Business Overview
7.5.3 Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Major Product Offerings
7.5.4 Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Revenue in Global (2016-2021)
7.5.5 Bristol-Myers Squibb (BMS) Key News
7.6 Bayer HealthCare
7.6.1 Bayer HealthCare Corporate Summary
7.6.2 Bayer HealthCare Business Overview
7.6.3 Bayer HealthCare Venous Thromboembolism Therapeutics Major Product Offerings
7.6.4 Bayer HealthCare Venous Thromboembolism Therapeutics Revenue in Global (2016-2021)
7.6.5 Bayer HealthCare Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Venous Thromboembolism Therapeutics Major Product Offerings
7.4.4 Pfizer Venous Thromboembolism Therapeutics Revenue in Global (2016-2021)
7.7.5 Pfizer Key News
7.8 Leo Pharma
7.8.1 Leo Pharma Corporate Summary
7.8.2 Leo Pharma Business Overview
7.8.3 Leo Pharma Venous Thromboembolism Therapeutics Major Product Offerings
7.8.4 Leo Pharma Venous Thromboembolism Therapeutics Revenue in Global (2016-2021)
7.8.5 Leo Pharma Key News
7.9 Portola Pharmaceuticals
7.9.1 Portola Pharmaceuticals Corporate Summary
7.9.2 Portola Pharmaceuticals Business Overview
7.9.3 Portola Pharmaceuticals Venous Thromboembolism Therapeutics Major Product Offerings
7.9.4 Portola Pharmaceuticals Venous Thromboembolism Therapeutics Revenue in Global (2016-2021)
7.9.5 Portola Pharmaceuticals Key News
7.10 ThromboGenics
7.10.1 ThromboGenics Corporate Summary
7.10.2 ThromboGenics Business Overview
7.10.3 ThromboGenics Venous Thromboembolism Therapeutics Major Product Offerings
7.10.4 ThromboGenics Venous Thromboembolism Therapeutics Revenue in Global (2016-2021)
7.10.5 ThromboGenics Key News
7.11 Ionis Pharmaceuticals
7.11.1 Ionis Pharmaceuticals Corporate Summary
7.11.2 Ionis Pharmaceuticals Business Overview
7.11.3 Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Major Product Offerings
7.11.4 Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Revenue in Global (2016-2021)
7.11.5 Ionis Pharmaceuticals Key News
7.12 GlycoMimetics
7.12.1 GlycoMimetics Corporate Summary
7.12.2 GlycoMimetics Business Overview
7.12.3 GlycoMimetics Venous Thromboembolism Therapeutics Major Product Offerings
7.12.4 GlycoMimetics Venous Thromboembolism Therapeutics Revenue in Global (2016-2021)
7.12.5 GlycoMimetics Key News
7.13 BioInvent International
7.13.1 BioInvent International Corporate Summary
7.13.2 BioInvent International Business Overview
7.13.3 BioInvent International Venous Thromboembolism Therapeutics Major Product Offerings
7.13.4 BioInvent International Venous Thromboembolism Therapeutics Revenue in Global (2016-2021)
7.13.5 BioInvent International Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Venous Thromboembolism Therapeutics Market Opportunities & Trends in Global Market
Table 2. Venous Thromboembolism Therapeutics Market Drivers in Global Market
Table 3. Venous Thromboembolism Therapeutics Market Restraints in Global Market
Table 4. Key Players of Venous Thromboembolism Therapeutics in Global Market
Table 5. Top Venous Thromboembolism Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Venous Thromboembolism Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Venous Thromboembolism Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Venous Thromboembolism Therapeutics Product Type
Table 9. List of Global Tier 1 Venous Thromboembolism Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Venous Thromboembolism Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Johnson & Johnson
Sanofi
Boehringer Ingelheim
Daiichi Sankyo
Bristol-Myers Squibb (BMS)
Bayer HealthCare
Pfizer
Leo Pharma
Portola Pharmaceuticals
ThromboGenics
Ionis Pharmaceuticals
GlycoMimetics
BioInvent International

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE